A detailed history of Qube Research & Technologies LTD transactions in Celcuity Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 63,575 shares of CELC stock, worth $599,512. This represents 0.0% of its overall portfolio holdings.

Number of Shares
63,575
Previous 96,276 33.97%
Holding current value
$599,512
Previous $1.44 Million 42.02%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

SELL
$12.0 - $16.35 $392,412 - $534,661
-32,701 Reduced 33.97%
63,575 $832,000
Q3 2024

Nov 14, 2024

BUY
$13.98 - $19.15 $1.35 Million - $1.84 Million
96,276 New
96,276 $1.44 Million
Q4 2023

Feb 13, 2024

BUY
$8.7 - $15.02 $21,323 - $36,814
2,451 New
2,451 $35,000
Q1 2023

May 15, 2023

BUY
$9.4 - $12.82 $196,215 - $267,604
20,874 New
20,874 $213,000

Others Institutions Holding CELC

About Celcuity Inc.


  • Ticker CELC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 14,941,300
  • Market Cap $141M
  • Description
  • Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...
More about CELC
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.